Devyser wins SEK 16.8M tender for genetic testing in Italy

Devyser Diagnostics was awarded a three-year tender by AOU Città Della Salute e della Scienza in Turin, Italy, for NGS genetic tests covering CFTR, BRCA and Thalassemia, with an indicative order value of SEK 16.8 million.

“This tender underscores Devyser’s continued excellence in delivering high-quality genetic testing solutions and its commitment to advancing precision medicine.”investors.devyser.com

• 1 source
• investors.devyser.comDevyser secures a major SEK 16.8M tender in Italy with 30% growth | Devyser Diagnostics ABApr 28, 2026

Summarized from public sources; check the original articles before acting on it.